$7.56+0.10 (+1.34%)
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific.
Materialise NV in the Technology sector is trading at $7.56 with a market capitalization of $390M. Wall Street consensus targets $8.96 (3 analysts), implying a +18.5% move over the next 12 months. The stock is currently near its 52-week high of $7.67, remaining 27.3% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $66.28Mβ | $70.16Mβ | $77.80Mβ | $64.83Mβ | $66.38M |
| Gross Profit | $37.89Mβ | $40.78Mβ | $44.21Mβ | $37.78Mβ | $36.73M |
| Operating Income | $2.09Mβ | $3.11Mβ | $2.96Mβ | $2.73Mβ | $575,000 |
| Net Income | $1.82Mβ | $6.21Mβ | $2.17Mβ | $197,000β | -$533,000 |
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Mat...
European equities traded in the US as American depositary receipts were marginally higher late Frida
European equities traded in the US as American depositary receipts opened the week slightly lower la

Medical revenue surged 9.6% while management raised full-year profit guidance.
European equities traded in the US as American depositary receipts were marginally higher late Frida
Materialise NV (MTLS) raises full-year adjusted EBIT guidance amid strong Medical segment performance and a 40% surge in Aerospace revenue.